Paper28422733
The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
Wu HT and 4 others. Oncotarget, 2017. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma. Papers, record 28422733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28422733
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| STAT3 Transcription Factor | Major topic |
| STAT5 Transcription Factor | Major topic |
| STAT6 Transcription Factor | Major topic |
| Transcription, Genetic | Major topic |
| Adult | |
| Aged | |
| Biomarkers | |
| Computational Biology | |
| Databases, Nucleic Acid | |
| Female | |
| Gene Expression Profiling | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Kaplan-Meier Estimate | |
| Middle Aged | |
| Mutation | |
| Neoplasm Grading | |
| Neoplasm Staging | |
| Prognosis | |
| Transcriptome |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10458605 | Stat3 as an oncogene. | Cell | 1999 | https://conductscience.org/library/papers/10458605 | PubMed |
| 2 | 12082548 | STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells. | Neoplasia | 2002 | https://conductscience.org/library/papers/12082548 | PubMed |
| 3 | 12621061 | Signal transduction pathways regulated by prolactin and Src result in different conformations of activated Stat5b. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12621061 | PubMed |
| 4 | 1496401 | Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. | Science | 1992 | https://conductscience.org/library/papers/1496401 | PubMed |
| 5 | 15034139 | Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. | Mol Biol Cell | 2004 | https://conductscience.org/library/papers/15034139 | PubMed |
| 6 | 15068665 | ONCOMINE: a cancer microarray database and integrated data-mining platform. | Neoplasia | 2004 | https://conductscience.org/library/papers/15068665 | PubMed |
| 7 | 15509516 | Roles and regulation of stat family transcription factors in human breast cancer. | Am J Pathol | 2004 | https://conductscience.org/library/papers/15509516 | PubMed |
| 8 | 15923602 | Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. | Mol Cell Biol | 2005 | https://conductscience.org/library/papers/15923602 | PubMed |
| 9 | 16094372 | Identification of JAK/STAT signalling components by genome-wide RNA interference. | Nature | 2005 | https://conductscience.org/library/papers/16094372 | PubMed |
| 10 | 16473279 | X chromosomal abnormalities in basal-like human breast cancer. | Cancer Cell | 2006 | https://conductscience.org/library/papers/16473279 | PubMed |
| 11 | 16954437 | Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer. | Endocr Relat Cancer | 2006 | https://conductscience.org/library/papers/16954437 | PubMed |
| 12 | 17639043 | Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer. | Endocr Relat Cancer | 2007 | https://conductscience.org/library/papers/17639043 | PubMed |
| 13 | 18342537 | IL-4-induced Stat6 activities affect apoptosis and gene expression in breast cancer cells. | Cytokine | 2008 | https://conductscience.org/library/papers/18342537 | PubMed |
| 14 | 18438415 | Stromal gene expression predicts clinical outcome in breast cancer. | Nat Med | 2008 | https://conductscience.org/library/papers/18438415 | PubMed |
| 15 | 18550772 | Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. | Mol Endocrinol | 2008 | https://conductscience.org/library/papers/18550772 | PubMed |
| 16 | 19574486 | Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. | Clin Med Res | 2009 | https://conductscience.org/library/papers/19574486 | PubMed |
| 17 | 20020197 | An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. | Breast Cancer Res Treat | 2010 | https://conductscience.org/library/papers/20020197 | PubMed |
| 18 | 20967621 | RNA and DNA microarrays. | Methods Mol Biol | 2011 | https://conductscience.org/library/papers/20967621 | PubMed |
| 19 | 21076615 | Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden. | Neoplasia | 2010 | https://conductscience.org/library/papers/21076615 | PubMed |
| 20 | 21373875 | TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab. | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/21373875 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42801147 | The Multifaceted Roles of STAT6: Implications for Precision Immunotherapeutics. | Immunotargets Ther | 2026 | https://conductscience.org/library/papers/42801147 | PubMed |
| 40507264 | The Roles of STAT3 and STAT5 in Breast Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40507264 | PubMed |
| 38124049 | Notch3 restricts metastasis of breast cancers through regulation of the JAK/STAT5A signaling pathway. | BMC Cancer | 2023 | https://conductscience.org/library/papers/38124049 | PubMed |
| 37101124 | moBRCA-net: a breast cancer subtype classification framework based on multi-omics attention neural networks. | BMC Bioinformatics | 2023 | https://conductscience.org/library/papers/37101124 | PubMed |
| 35995341 | STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/35995341 | PubMed |
| 35966307 | Development of novel gene signatures for the risk stratification of prognosis and diagnostic prediction of osteosarcoma patients using bioinformatics analysis. | Transl Cancer Res | 2022 | https://conductscience.org/library/papers/35966307 | PubMed |
| 35833783 | Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. | Clin Cancer Res | 2022 | https://conductscience.org/library/papers/35833783 | PubMed |
| 35646925 | Lestaurtinib Has the Potential to Inhibit the Proliferation of Hepatocellular Carcinoma Uncovered by Bioinformatics Analysis and Pharmacological Experiments. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35646925 | PubMed |
| 35207629 | High Expression of Interferon Pathway Genes CXCL10 and STAT2 Is Associated with Activated T-Cell Signature and Better Outcome of Oral Cancer Patients. | J Pers Med | 2022 | https://conductscience.org/library/papers/35207629 | PubMed |
| 35117463 | Expression of CYB5D2 is associated with epithelial-mesenchymal transition and survival rates in patients with cervical cancer. | Transl Cancer Res | 2020 | https://conductscience.org/library/papers/35117463 | PubMed |
| 35020130 | Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer. | Breast Cancer | 2022 | https://conductscience.org/library/papers/35020130 | PubMed |
| 34572592 | Molecular Biology Networks and Key Gene Regulators for Inflammatory Biomarkers Shared by Breast Cancer Development: Multi-Omics Systems Analysis. | Biomolecules | 2021 | https://conductscience.org/library/papers/34572592 | PubMed |
| 33801973 | EGCG Inhibits Adipose-Derived Mesenchymal Stem Cells Differentiation into Adipocytes and Prevents a STAT3-Mediated Paracrine Oncogenic Control of Triple-Negative Breast Cancer Cell Invasive Phenotype. | Molecules | 2021 | https://conductscience.org/library/papers/33801973 | PubMed |
| 33042401 | Identification of immune checkpoint inhibitors and biomarkers among STAT family in stomach adenocarcinoma. | Am J Transl Res | 2020 | https://conductscience.org/library/papers/33042401 | PubMed |
| 32528869 | SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer. | Front Oncol | 2020 | https://conductscience.org/library/papers/32528869 | PubMed |
| 32525891 | Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells. | PLoS One | 2020 | https://conductscience.org/library/papers/32525891 | PubMed |
| 31286834 | MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways. | Cell Cycle | 2019 | https://conductscience.org/library/papers/31286834 | PubMed |
| 30068360 | Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer. | J Transl Med | 2018 | https://conductscience.org/library/papers/30068360 | PubMed |
| 29326301 | Prognostic roles of signal transducers and activators of transcription family in human breast cancer. | Biosci Rep | 2018 | https://conductscience.org/library/papers/29326301 | PubMed |
Genes38
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28422733
GET https://conductscience.org/api/papers/v1/28422733/references?page=2